Industry Verticals »

All Categories

Insights »

About TMR »

Companion Diagnostics Market

Companion Diagnostics Market (Product and Services: Assays, Kits, and Reagents, Instruments & Systems and Software & Services; Technology: Polymerase Chain Reaction (PCR), Next-generation Sequencing (NGS), In-situ Hybridisation (ISH), Immunohistochemistry (IHC), Magnetic Resonance Imaging (MRI) and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2026–2036

Companion Diagnostics Market Outlook 2036

The global companion diagnostics market size was valued at US$ 1.2 Bn in 2025 and is projected to reach US$ 3.6 Bn by 2036, expanding at a CAGR of 10.4% from 2026 to 2036. The market growth is driven by innovations in genomic and molecular testing technologies and growing need for targeted therapies in oncology.

Market Size & Highlights

  • The companion diagnostics market reached US$ 1.2 Bn in 2025.
  • The market is expected to climb to US$ 3.6 Bn by 2036.
  • The companion diagnostics industry is anticipated to expand at a CAGR of 10.4% from 2026 to 2036.
  • Top companies in the market include F. Hoffmann‑La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., QIAGEN N.V., Abbott Laboratories, etc.
  • North America dominated the market in 2025, holding the largest revenue share of 37.2%.
  • By technology, the next-generation sequencing (NGS) segment held the major market share of 38.2% in 2025.

Companion Diagnostics Market By Revenue

Analysts’ Viewpoint

The companion diagnostics market is witnessing substantial growth, which is mainly attributed to the widespread use of personalized medicine and customized treatment methods. Companion diagnostics are basically the healthcare providers' most important tools in figuring out which patients will benefit the most from a certain therapeutic drug, thus not only increasing the treatment efficacy but also minimizing the side effects. As cancer is the major focus of this sector, with biomarkers playing an increasingly important role in patient stratification, the demand for companion diagnostics is projected to go up.

In addition, the development of genomic technologies and the growing number of targeted therapies are driving the market growth, with many pharmaceutical companies partnering in the creation of companion diagnostics along with their drugs. Moreover, regulatory support especially from the FDA and EMA, is a significant factor in market boosting as these agencies grant diagnostic devices that go hand in hand with new therapeutics considerably faster market access.

There are still some issues such as the difficulties of discovering and validating biomarkers as well as setting up of reimbursement systems. Nevertheless, given that artificial intelligence is expected to be integrated into diagnostics, there is a possibility that this will not only result in increased precision but also speed up making clinical decisions. In general, the companion diagnostics market is at a stage where it has the potential for strong growth driven by innovative technology, regulatory support and an increasing focus on personalized healthcare solutions.

Companion Diagnostics Market Introduction

Companion diagnostics refer to medical devices or tests that aim to improve the effectiveness of certain therapeutic drugs through the discovery of patients who are most likely to respond positively to a particular course of treatment. These diagnostics play a vital role in the personalized medicine era, where treatments are customized based on individual patient characteristics instead of the conventional approach where everyone gets the same treatment. Essentially, the main purpose of companion diagnostics is to scrutinize biomarkers - be they proteomic, genetic, or the other molecular patterns that help predict the patients’ response to a specific drug.

The importance of companion diagnostics is most visible in oncology, where they help in choosing the most appropriate targeted therapies. The tests that find specific genetic mutations in cancer cells, which can help oncologists to prescribe drugs that have a higher probability of achieving the desired effects in patients. Apart from improving the effectiveness of treatments, this also reduces the risk of side effects caused by the use of drugs that are not effective.

Attribute Detail
Market Drivers
  • Innovations in Genomic and Molecular Testing Technologies
  • Growing Need for Targeted Therapies in Oncology
  • Favorable Policies Streamlining the Approval of Companion Diagnostics

Innovations in Genomic and Molecular Testing Technologies to Drive Companion Diagnostics Market Size

Innovations in genomic and molecular testing technologies play a major role in driving companion diagnostics market growth. They not only help to pinpoint biomarkers with great precision but also facilitate a perfect match of the treatment with a patient, especially in cancer cases. Next, generation sequencing (NGS), polymerase chain reaction (PCR), and liquid biopsy are among the technologies that enable obtaining and analyzing genetic material quickly and accurately.

NGS, for example, allows for thorough genomic profiling, thus enabling doctors to figure out what genetic factors are involved in a patient's condition, which in turn, helps in choosing the right medicines. Besides that, as these technologies are constantly being upgraded, the cost gets lower and the time for the test gets shorter. The more affordable and efficient the diagnostic tests are, the more likely it is that the majority of healthcare providers will make companion diagnostics a commonplace tool in precision medicine.

Growing Need for Targeted Therapies in Oncology Anticipated to Boost Companion Diagnostics Market Expansion

The oncology companion diagnostic market is largely influenced by the increasing need for targeted therapies. A deeper understanding of cancer biology reveals that cancer is not a single disease but rather various subtypes with diverse genetic mutations and molecular profiles.

Companion diagnostics are vital in this regard, as they help to identify the patients who will benefit most from the therapies. For instance, testing for the presence of certain mutations like BRCA1/2 in breast cancer or EGFR in lung cancer helps to treat physicians to choose the right medications.

As standard cancer therapies do not always work and tend to have a variety of side-effects, both - healthcare professionals and patients are leaning toward treatment plans that are more personalized, hence more effective and less problematic.

Besides, healthcare systems are continuing to introduce policies that favor the use of targeted therapies and the diagnostics tools that go along with them, thus promoting research and development in the field.

Attribute Detail
Key Opportunity
  • Advancements in Biomarker Discovery Technologies

Advancements in Biomarker Discovery Technologies Presents Significant Growth Opportunities for the Companion Diagnostics Market

Advances in biomarker discovery technologies are opening up a major market opportunity in the companion diagnostics sector. Biomarker discovery and validation are essential steps in the development of companion diagnostics that are used to guide therapy selection and patient treatment.

Recently, innovations in high throughput sequencing methods, mass spectrometry, and bioinformatics tools have drastically reshaped the biomarker discovery field allowing researchers to process huge volumes of biological data both rapidly and efficiently.

One example is next generation sequencing (NGS) technology that allows extensive genomic profiling that can identify mutations crucial to cancers. This capability significantly improves the identification of personalized therapies thereby amplifying therapeutic benefits.

Besides, liquid biopsy assays permit the capturing of circulating tumor DNA (ctDNA) and the other markers directly from plasma, thus offering an entirely noninvasive mode of tracking the disease as well as evaluating treatment efficacy.

The combination of artificial intelligence (AI) and machine learning with biomarker discovery is a further great innovation. Such methods can deal with very complicated datasets, and can spot the patterns and correlations that humans might miss. As a result, the discovery of new biomarkers is greatly sped up and the companion diagnostics become more accurate in their predictions.

Next-generation Sequencing (NGS) Technology Segment Driving Companion Diagnostics Market Growth

Companion Diagnostics Market By Type

Next, generation sequencing (NGS) technology is a major growth driver in the companion diagnostics market, mainly because it can supply comprehensive and precise genetic information. NGS enables the analysis of multiple genes and genetic variations to be done at the same time, thus the process can be up to several times more efficient as compared to traditional sequencing methods. This feature leads to the identification of biomarkers that are valuable for patient, targeted therapies, especially in the case of cancer. Additionally, the high throughput and cost, effectiveness of NGS facilitate its clinical application on a large scale, hence diagnostics can be performed within a very short time frame.

As medicine moves more toward personalization, the need for devices that can instantaneously and correctly determine treatments has risen considerably. Besides helping to detect particular mutations present in different types of cancer, NGS can also be used for tracking the status of a disease and how it is responding to medicine through the analysis of liquid biopsy samples.

In addition, combining NGS and bioinformatics software allows for improved therapeutic strategies based on an individual's genetic makeup. Furthermore, regulatory bodies have been supportive of NGS, based companion diagnostics by providing a fast track approval process, which is another factor that has boosted market growth. NGS has become a key technology that basically revolutionizes the development and use of companion diagnostics as healthcare moves towards precision medicine.

Regional Outlook of Companion Diagnostics Market

Companion Diagnostics Market By Region

Attribute Detail
Leading Region
  • North America

One of the important reasons for North America dominating the companion diagnostics market is that this region has an excellent healthcare system, a high level of investment in research and development, and a very well, functioning regulatory environment.

It should be noted that the U.S. is the leading biotech and pharmaceutical hub where most of the big names prioritize personalized medicine, which, in turn, is leading to a rise in demand for companion diagnostics. These companies dedicate a huge part of their budgets to R&D activities to discover and develop biomarkers that could potentially be used to achieve better therapeutic efficacy and thus improved patient outcomes.

Moreover, the regulatory landscape in North America along with the FDA backing is creating an environment where the concepts of companion diagnostics and new drug approvals go hand in hand. This kind of regulatory backing not only results in quicker validation and market launch of companion diagnostics but also leads to a competitive market environment that is innovation, friendly. Besides these, there are financial incentives like grants and tax exemptions for research activities which make the sector more profitable and hence attractive for investors.

The rising incidence of chronic diseases, especially cancer, is the main factor behind the increase in demand for market as healthcare providers constantly look for more efficient therapeutic strategies. Besides, the escalating trend of personalized healthcare is a good match with the North American patient demographic who, by now, have become quite knowledgeable and active in deciding their treatments. In sum, the combination of leading, edge technology, facilitating regulatory framework, and a patient, centric focus has firmly established North America's supremacy in this market.

Analysis of Key Players in Companion Diagnostics Market

F. Hoffmann‑La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., QIAGEN N.V., Abbott Laboratories, Illumina, Inc., Myriad Genetics, Inc., Foundation Medicine, Inc., Guardant Health, Inc., bioMérieux SA, Danaher Corporation, Caris Life Sciences, Quest Diagnostics, Inc. are the key players governing the global Companion Diagnostics Market.

Each of these players has been profiled in the companion diagnostics market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments in Companion Diagnostics Market

  • In January 2025, Roche revealed that the FDA had granted approval for a label expansion of the PATHWAY anti-Rabbit Monoclonal Primary Antibody*. This update facilitates the detection of patients with HR-positive, HER2-ultralow metastatic breast cancer who could qualify for treatment.
  • In August 2024, the FDA approved Illumina's cancer biomarker test, featuring two companion diagnostics to swiftly match patients with targeted therapies. This test analyzes 500 genes to profile solid tumors, enhancing the chances of identifying immuno-oncology or clinically actionable biomarkers. TSO Comprehensive is FDA-approved as a CDx for detecting NTRK gene fusions in solid tumors, aiding treatment with Bayer’s VITRAKVI (larotrectinib).
  • In April 2024, Labcorp, a global provider of innovative laboratory services, announced that the FDA has approved its nAbCte Anti-AAVRh74var HB-FE Assay. This companion diagnostic (CDx) is designed to assess patient eligibility for treatment with BEQVZ™, Pfizer's newly FDA-approved gene therapy for hemophilia B.

Companion Diagnostics Market Snapshot

Attribute Detail
Size in 2025 US$ 1.2 Bn
Forecast Value in 2036 More than US$ 3.6 Bn
CAGR 10.4%
Forecast Period 2026-2036
Historical Data Available for 2021-2024
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape
  • Competition Matrix
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation By Product and Services
  • Assays, Kits, and Reagents
  • Instruments & Systems
  • Software & Services
By Technology
  • Polymerase Chain Reaction (PCR)
  • Next-generation Sequencing (NGS)
  • In-situ Hybridization (ISH)
  • Immunohistochemistry (IHC)
  • Magnetic Resonance Imaging (MRI)
  • Others
By Sample Type
  • Tissue Samples
  • Blood Samples
  • Others
By Indication
  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Neurological Disorders
  • Others
By End-user
  • Pharmaceutical and Biotechnology Companies
  • Reference Laboratories
  • Control Research Organizations
  • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • The Netherlands
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • ASEAN
  • Brazil
  • Mexico
  • Argentina
  • GCC Countries
  • South Africa
Companies Profiled
  • F. Hoffmann‑La Roche AG
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • QIAGEN N.V.
  • Abbott Laboratories
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • Foundation Medicine, Inc.
  • Guardant Health, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • Caris Life Sciences
  • Quest Diagnostics, Inc.
  • Other Prominent Players
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global companion diagnostics market in 2025?

The global companion diagnostics market was valued at US$ 1.2 Bn in 2025

What is the projected size of the companion diagnostics Industry by 2036?

The global companion diagnostics Industry is projected to cross US$ 3.6 Bn by the end of 2036

What are the factors driving the companion diagnostics market?

Innovations in genomic and molecular testing technologies and growing need for targeted therapies in oncology

What is the companion diagnostics market expected to grow during the forecast period?

The global companion diagnostics market is anticipated to grow at a CAGR of 10.4% from 2026 to 2036

Which region is expected to dominate the companion diagnostics market during the forecast period?

North America is expected to account for the largest share from 2026 to 2036

Who are the prominent companion diagnostics providers?

F. Hoffmann‑La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., QIAGEN N.V., Abbott Laboratories, Illumina, Inc., Myriad Genetics, Inc., Foundation Medicine, Inc., Guardant Health, Inc., bioMérieux SA, Danaher Corporation, Caris Life Sciences, Quest Diagnostics, Inc. and others

  1. Preface
    • Market Definition and Scope
    • Market Segmentation
    • Key Research Objectives
    • Research Highlights
  2. Assumptions and Research Methodology
  3. Executive Summary: Global Companion Diagnostics Market
  4. Market Overview
    • Introduction
      • Segment Definition
      • Industry Evolution / Developments
    • Overview
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Global Companion Diagnostics Market Analysis and Forecast, 2021-2036
      • Market Revenue Projections (US$ Bn)
  5. Key Insights
    • Healthcare Expenditure across Key Countries / Regions
    • Pricing Trends
    • Regulatory Scenario across Key Countries
    • PORTER’s Five Forces Analysis
    • PESTLE Analysis
    • Go-to-Market Strategy for New Market Entrants
    • Key Purchase Metrics for End-users
    • Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions)
    • Benchmarking of the Products Offered by the Leading Competitors
  6. Global Companion Diagnostics Market Analysis and Forecast, by Product and Services
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Attractiveness Analysis, by Product and Services
  7. Global Companion Diagnostics Market Analysis and Forecast, by Technology
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Attractiveness Analysis, by Technology
  8. Global Companion Diagnostics Market Analysis and Forecast, by Sample Type
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Attractiveness Analysis, by Sample Type
  9. Global Companion Diagnostics Market Analysis and Forecast, by Indication
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Attractiveness Analysis, by Indication
  10. Global Companion Diagnostics Market Analysis and Forecast, by End-user
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis, by End-user
  11. Global Companion Diagnostics Market Analysis and Forecast, by Region
    • Key Findings
    • Market Value Forecast, by Region, 2021-2036
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
    • Market Attractiveness Analysis, by Region
  12. North America Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • U.S.
      • Canada
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
      • By Country/Sub-region
  13. U.S. Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  14. Canada Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  15. Europe Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • The Netherlands
      • Rest of Europe
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
      • By Country/Sub-region
  16. Germany Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  17. UK Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  18. France Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  19. Italy Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  20. Spain Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  21. The Netherlands Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  22. Rest of Europe Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  23. Asia Pacific Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • China
      • India
      • Japan
      • South Korea
      • ASEAN
      • Australia
      • Rest of Asia Pacific
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
      • By Country/Sub-region
  24. China Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  25. India Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  26. Japan Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  27. South Korea Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  28. ASEAN Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  29. Australia Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  30. Rest of Asia Pacific Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  31. Latin America Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
      • By Country/Sub-region
  32. Brazil Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  33. Mexico Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  34. Argentina Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  35. Rest of Latin America Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  36. Middle East and Africa Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • GCC Countries
      • South Africa
      • Rest of Middle East and Africa
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
      • By Country/Sub-region
  37. GCC Countries Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  38. South Africa Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  39. Rest of Middle East and Africa Companion Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product and Services, 2021-2036
      • Assays, Kits, and Reagents
      • Instruments & Systems
      • Software & Services
    • Market Value Forecast, by Technology, 2021-2036
      • Polymerase Chain Reaction (PCR)
      • Next-generation Sequencing (NGS)
      • In-situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Magnetic Resonance Imaging (MRI)
      • Others
    • Market Value Forecast, by Sample Type, 2021-2036
      • Tissue Samples
      • Blood Samples
      • Others
    • Market Value Forecast, by Indication, 2021-2036
      • Oncology
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical and Biotechnology Companies
      • Reference Laboratories
      • Control Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Product and Services
      • By Technology
      • By Sample Type
      • By Indication
      • By End-user
  40. Competition Landscape
    • Market Player - Competition Matrix (By Tier and Size of Companies)
    • Market Share Analysis, by Company (2025)
    • Company Profiles
      • F. Hoffmann La Roche AG
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Thermo Fisher Scientific Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Agilent Technologies, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • QIAGEN N.V.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Abbott Laboratories
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Illumina, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Myriad Genetics, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Foundation Medicine, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Guardant Health, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • bioMérieux SA
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Danaher Corporation
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Caris Life Sciences
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Quest Diagnostics, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments

List of Tables

Table 01: Global Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 02: Global Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 03: Global Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 04: Global Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 05: Global Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 06: Global Companion Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 07: North America Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 08: North America Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 09: North America Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 10: North America Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 11: North America Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 12: North America Companion Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 13: U.S. Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 14: U.S. Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 15: U.S. Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 16: U.S. Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 17: U.S. Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 18: Canada Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 19: Canada Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 20: Canada Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 21: Canada Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 22: Canada Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 23: Europe Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 24: Europe Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 25: Europe Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 26: Europe Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 27: Europe Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 28: Europe Companion Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 29: Germany Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 30: Germany Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 31: Germany Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 32: Germany Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 33: Germany Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 34: U.K. Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 35: U.K. Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 36: U.K. Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 37: U.K. Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 38: U.K. Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 39: France Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 40: France Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 41: France Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 42: France Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 43: France Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 44: Italy Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 45: Italy Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 46: Italy Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 47: Italy Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 48: Italy Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 49: Spain Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 50: Spain Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 51: Spain Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 52: Spain Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 53: Spain Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 54: The Netherlands Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 55: The Netherlands Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 56: The Netherlands Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 57: The Netherlands Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 58: The Netherlands Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 59: Rest of Europe Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 60: Rest of Europe Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 61: Rest of Europe Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 62: Rest of Europe Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 63: Rest of Europe Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 64: Asia Pacific Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 65: Asia Pacific Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 66: Asia Pacific Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 67: Asia Pacific Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 68: Asia Pacific Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 69: Asia Pacific Companion Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 70: China Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 71: China Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 72: China Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 73: China Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 74: China Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 75: Japan Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 76: Japan Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 77: Japan Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 78: Japan Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 79: Japan Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 80: India Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 81: India Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 82: India Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 83: India Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 84: India Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 85: South Korea Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 86: South Korea Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 87: South Korea Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 88: South Korea Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 89: South Korea Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 90: ASEAN Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 91: ASEAN Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 92: ASEAN Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 93: ASEAN Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 94: ASEAN Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 95: Australia Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 96: Australia Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 97: Australia Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 98: Australia Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 99: Australia Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 100: Rest of Asia Pacific Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 101: Rest of Asia Pacific Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 102: Rest of Asia Pacific Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 103: Rest of Asia Pacific Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 104: Rest of Asia Pacific Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 105: Latin America Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 106: Latin America Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 107: Latin America Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 108: Latin America Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 109: Latin America Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 110: Latin America Companion Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 111: Brazil Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 112: Brazil Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 113: Brazil Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 114: Brazil Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 115: Brazil Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 116: Mexico Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 117: Mexico Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 118: Mexico Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 119: Mexico Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 120: Mexico Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 121: Argentina Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 122: Argentina Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 123: Argentina Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 124: Argentina Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 125: Argentina Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 126: Rest of Latin America Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 127: Rest of Latin America Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 128: Rest of Latin America Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 129: Rest of Latin America Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 130: Rest of Latin America Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 131: Middle East and Africa Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 132: Middle East and Africa Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 133: Middle East and Africa Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 134: Middle East and Africa Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 135: Middle East and Africa Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 136: Middle East and Africa Companion Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 137: GCC Countries Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 138: GCC Countries Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 139: GCC Countries Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 140: GCC Countries Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 141: GCC Countries Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 142: South Africa Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 143: South Africa Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 144: South Africa Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 145: South Africa Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 146: South Africa Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 147: Rest of Middle East and Africa Companion Diagnostics Market Value (US$ Bn) Forecast, by Product and Services, 2021 to 2036
Table 148: Rest of Middle East and Africa Companion Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 149: Rest of Middle East and Africa Companion Diagnostics Market Value (US$ Bn) Forecast, by Sample Type, 2021 to 2036
Table 150: Rest of Middle East and Africa Companion Diagnostics Market Value (US$ Bn) Forecast, by Indication, 2021 to 2036
Table 151: Rest of Middle East and Africa Companion Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036

List of Figures

Figure 01: Global Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 02: Global Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 03: Global Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 04: Global Companion Diagnostics Market Revenue (US$ Bn), by Assays, Kits, and Reagents, 2021 to 2036
Figure 05: Global Companion Diagnostics Market Revenue (US$ Bn), by Instruments & Systems, 2021 to 2036
Figure 06: Global Companion Diagnostics Market Revenue (US$ Bn), by Software & Services, 2021 to 2036
Figure 07: Global Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 08: Global Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 09: Global Companion Diagnostics Market Revenue (US$ Bn), by Polymerase Chain Reaction (PCR), 2021 to 2036
Figure 10: Global Companion Diagnostics Market Revenue (US$ Bn), by Next-generation Sequencing (NGS), 2021 to 2036
Figure 11: Global Companion Diagnostics Market Revenue (US$ Bn), by In-situ Hybridization (ISH), 2021 to 2036
Figure 12: Global Companion Diagnostics Market Revenue (US$ Bn), by Immunohistochemistry (IHC), 2021 to 2036
Figure 13: Global Companion Diagnostics Market Revenue (US$ Bn), by Magnetic Resonance Imaging (MRI), 2021 to 2036
Figure 14: Global Companion Diagnostics Market Revenue (US$ Bn), by Others, 2021 to 2036
Figure 15: Global Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 16: Global Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 17: Global Companion Diagnostics Market Revenue (US$ Bn), by Tissue Samples, 2021 to 2036
Figure 18: Global Companion Diagnostics Market Revenue (US$ Bn), by Blood Samples, 2021 to 2036
Figure 19: Global Companion Diagnostics Market Revenue (US$ Bn), by Others, 2021 to 2036
Figure 20: Global Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 21: Global Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 22: Global Companion Diagnostics Market Revenue (US$ Bn), by Oncology, 2021 to 2036
Figure 23: Global Companion Diagnostics Market Revenue (US$ Bn), by Infectious Diseases, 2021 to 2036
Figure 24: Global Companion Diagnostics Market Revenue (US$ Bn), by Cardiovascular Diseases, 2021 to 2036
Figure 25: Global Companion Diagnostics Market Revenue (US$ Bn), by Neurological Disorders, 2021 to 2036
Figure 26: Global Companion Diagnostics Market Revenue (US$ Bn), by Others, 2021 to 2036
Figure 27: Global Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 28: Global Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 29: Global Companion Diagnostics Market Revenue (US$ Bn), by Pharmaceutical and Biotechnology Companies, 2021 to 2036
Figure 30: Global Companion Diagnostics Market Revenue (US$ Bn), by Reference Laboratories, 2021 to 2036
Figure 31: Global Companion Diagnostics Market Revenue (US$ Bn), by Control Research Organizations, 2021 to 2036
Figure 32: Global Companion Diagnostics Market Revenue (US$ Bn), by Others, 2021 to 2036
Figure 33: Global Companion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 34: Global Companion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 35: North America Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 36: North America Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 37: North America Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 38: North America Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 39: North America Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 40: North America Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 41: North America Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 42: North America Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 43: North America Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 44: North America Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 45: North America Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 46: North America Companion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 47: North America Companion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 48: U.S. Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 49: U.S. Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 50: U.S. Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 51: U.S. Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 52: U.S. Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 53: U.S. Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 54: U.S. Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 55: U.S. Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 56: U.S. Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 57: U.S. Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 58: U.S. Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 59: Canada Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 60: Canada Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 61: Canada Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 62: Canada Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 63: Canada Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 64: Canada Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 65: Canada Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 66: Canada Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 67: Canada Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 68: Canada Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 69: Canada Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 70: Europe Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 71: Europe Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 72: Europe Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 73: Europe Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 74: Europe Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 75: Europe Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 76: Europe Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 77: Europe Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 78: Europe Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 79: Europe Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 80: Europe Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 81: Europe Companion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 82: Europe Companion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 83: Germany Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 84: Germany Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 85: Germany Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 86: Germany Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 87: Germany Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 88: Germany Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 89: Germany Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 90: Germany Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 91: Germany Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 92: Germany Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 93: Germany Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 94: U.K. Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 95: U.K. Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 96: U.K. Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 97: U.K. Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 98: U.K. Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 99: U.K. Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 100: U.K. Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 101: U.K. Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 102: U.K. Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 103: U.K. Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 104: U.K. Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 105: France Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 106: France Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 107: France Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 108: France Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 109: France Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 110: France Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 111: France Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 112: France Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 113: France Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 114: France Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 115: France Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 116: Italy Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 117: Italy Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 118: Italy Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 119: Italy Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 120: Italy Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 121: Italy Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 122: Italy Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 123: Italy Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 124: Italy Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 125: Italy Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 126: Italy Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 127: Spain Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 128: Spain Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 129: Spain Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 130: Spain Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 131: Spain Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 132: Spain Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 133: Spain Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 134: Spain Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 135: Spain Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 136: Spain Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 137: Spain Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 138: The Netherlands Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 139: The Netherlands Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 140: The Netherlands Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 141: The Netherlands Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 142: The Netherlands Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 143: The Netherlands Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 144: The Netherlands Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 145: The Netherlands Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 146: The Netherlands Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 147: The Netherlands Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 148: The Netherlands Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 149: Rest of Europe Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 150: Rest of Europe Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 151: Rest of Europe Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 152: Rest of Europe Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 153: Rest of Europe Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 154: Rest of Europe Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 155: Rest of Europe Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 156: Rest of Europe Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 157: Rest of Europe Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 158: Rest of Europe Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 159: Rest of Europe Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 160: Asia Pacific Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 161: Asia Pacific Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 162: Asia Pacific Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 163: Asia Pacific Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 164: Asia Pacific Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 165: Asia Pacific Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 166: Asia Pacific Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 167: Asia Pacific Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 168: Asia Pacific Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 169: Asia Pacific Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 170: Asia Pacific Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 171: Asia Pacific Companion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 172: Asia Pacific Companion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 173: China Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 174: China Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 175: China Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 176: China Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 177: China Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 178: China Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 179: China Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 180: China Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 181: China Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 182: China Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 183: China Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 184: Japan Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 185: Japan Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 186: Japan Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 187: Japan Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 188: Japan Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 189: Japan Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 190: Japan Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 191: Japan Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 192: Japan Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 193: Japan Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 194: Japan Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 195: India Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 196: India Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 197: India Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 198: India Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 199: India Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 200: India Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 201: India Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 202: India Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 203: India Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 204: India Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 205: India Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 206: South Korea Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 207: South Korea Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 208: South Korea Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 209: South Korea Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 210: South Korea Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 211: South Korea Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 212: South Korea Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 213: South Korea Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 214: South Korea Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 215: South Korea Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 216: South Korea Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 217: ASEAN Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 218: ASEAN Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 219: ASEAN Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 220: ASEAN Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 221: ASEAN Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 222: ASEAN Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 223: ASEAN Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 224: ASEAN Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 225: ASEAN Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 226: ASEAN Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 227: ASEAN Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 228: Australia Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 229: Australia Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 230: Australia Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 231: Australia Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 232: Australia Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 233: Australia Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 234: Australia Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 235: Australia Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 236: Australia Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 237: Australia Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 238: Australia Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 239: Rest of Asia Pacific Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 240: Rest of Asia Pacific Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 241: Rest of Asia Pacific Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 242: Rest of Asia Pacific Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 243: Rest of Asia Pacific Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 244: Rest of Asia Pacific Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 245: Rest of Asia Pacific Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 246: Rest of Asia Pacific Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 247: Rest of Asia Pacific Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 248: Rest of Asia Pacific Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 249: Rest of Asia Pacific Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 250: Latin America Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 251: Latin America Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 252: Latin America Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 253: Latin America Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 254: Latin America Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 255: Latin America Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 256: Latin America Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 257: Latin America Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 258: Latin America Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 259: Latin America Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 260: Latin America Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 261: Latin America Companion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 262: Latin America Companion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 263: Brazil Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 264: Brazil Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 265: Brazil Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 266: Brazil Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 267: Brazil Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 268: Brazil Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 269: Brazil Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 270: Brazil Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 271: Brazil Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 272: Brazil Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 273: Brazil Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 274: Mexico Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 275: Mexico Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 276: Mexico Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 277: Mexico Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 278: Mexico Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 279: Mexico Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 280: Mexico Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 281: Mexico Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 282: Mexico Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 283: Mexico Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 284: Mexico Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 285: Argentina Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 286: Argentina Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 287: Argentina Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 288: Argentina Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 289: Argentina Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 290: Argentina Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 291: Argentina Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 292: Argentina Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 293: Argentina Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 294: Argentina Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 295: Argentina Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 296: Rest of Latin America Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 297: Rest of Latin America Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 298: Rest of Latin America Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 299: Rest of Latin America Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 300: Rest of Latin America Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 301: Rest of Latin America Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 302: Rest of Latin America Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 303: Rest of Latin America Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 304: Rest of Latin America Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 305: Rest of Latin America Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 306: Rest of Latin America Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 307: Middle East and Africa Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 308: Middle East and Africa Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 309: Middle East and Africa Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 310: Middle East and Africa Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 311: Middle East and Africa Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 312: Middle East and Africa Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 313: Middle East and Africa Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 314: Middle East and Africa Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 315: Middle East and Africa Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 316: Middle East and Africa Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 317: Middle East and Africa Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 318: Middle East and Africa Companion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 319: Middle East and Africa Companion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 320: GCC Countries Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 321: GCC Countries Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 322: GCC Countries Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 323: GCC Countries Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 324: GCC Countries Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 325: GCC Countries Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 326: GCC Countries Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 327: GCC Countries Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 328: GCC Countries Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 329: GCC Countries Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 330: GCC Countries Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 331: South Africa Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 332: South Africa Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 333: South Africa Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 334: South Africa Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 335: South Africa Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 336: South Africa Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 337: South Africa Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 338: South Africa Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 339: South Africa Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 340: South Africa Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 341: South Africa Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 342: Rest of Middle East and Africa Companion Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 343: Rest of Middle East and Africa Companion Diagnostics Market Value Share Analysis, by Product and Services, 2025 and 2036
Figure 344: Rest of Middle East and Africa Companion Diagnostics Market Attractiveness Analysis, by Product and Services, 2026 to 2036
Figure 345: Rest of Middle East and Africa Companion Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 346: Rest of Middle East and Africa Companion Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 347: Rest of Middle East and Africa Companion Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 348: Rest of Middle East and Africa Companion Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 349: Rest of Middle East and Africa Companion Diagnostics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 350: Rest of Middle East and Africa Companion Diagnostics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 351: Rest of Middle East and Africa Companion Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 352: Rest of Middle East and Africa Companion Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036

Copyright © Transparency Market Research, Inc. All Rights reserved

Companion Diagnostics Market

Buy This ReportBuy Now